AKT1 and neoplasm: In addition, in EWS the phosphatidylinositol-3 kinase/AKT (PI3K/AKT) and mitogen-activated protein kinase (MAPK) pathways have been shown to protect tumor cells from apoptosis and promote drug resistance [21, 22].